CTIM-12. A PHASE I CLINICAL TRIAL ON THE INTRACRANIAL ADMINISTRATION OF INCREASING DOSES OF IPILIMUMAB PLUS FIXED DOSE NIVOLUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGB)

Authors: Wietse Geens, Julia Katharina Schwarze, Jens Tijtgat, Louise Lescrauwaet, Sandra Tuyaerts, Xenia Geeraerts, Latoya Stevens, Anne-Marie Vanbinst, Hendrik Everaert, Michaël Bruneau, Johnny Duerinck, Bart Neyns

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.244

Source: Full article

CTIM-12. A PHASE I CLINICAL TRIAL ON THE INTRACRANIAL ADMINISTRATION OF INCREASING DOSES OF IPILIMUMAB PLUS FIXED DOSE NIVOLUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGB)

Abstract